Research Summary
Plasma fractionation is a process used in the pharmaceutical and medical industries to separate and purify specific components from blood plasma. Blood plasma is the liquid portion of blood that remains after red and white blood cells and platelets have been removed. Plasma fractionation typically involves a series of steps, including separation, filtration, and purification, to isolate valuable proteins and other components from plasma. These isolated components, such as immunoglobulins, clotting factors, and albumin, are crucial for various medical therapies, including the treatment of immunodeficiency disorders, hemophilia, and other conditions. Plasma fractionation plays a key role in producing a range of therapeutic products derived from human plasma, contributing to advancements in medical treatments and ensuring a safe and reliable supply of plasma-derived medications.
According to DIResearch's in-depth investigation and research, the global Plasma Fractionation market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Plasma Fractionation include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Biological Vaccine, Tiantan Biological, Shuanglin Bio-Pharmacy, Boya Bio-Pharmaceutical, Yuanda Shuyang Pharmaceutical, Weiguang? Biological, KM Biologics etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Plasma Fractionation. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Plasma Fractionation market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Plasma Fractionation market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Plasma Fractionation industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Plasma Fractionation Include:
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Biological Vaccine
Tiantan Biological
Shuanglin Bio-Pharmacy
Boya Bio-Pharmaceutical
Yuanda Shuyang Pharmaceutical
Weiguang? Biological
KM Biologics
Plasma Fractionation Product Segment Include:
Albumin
Immune Globulin
Coagulation Factor
Others
Plasma Fractionation Product Application Include:
Immunology
Hematology
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Plasma Fractionation Industry PESTEL Analysis
Chapter 3: Global Plasma Fractionation Industry Porter's Five Forces Analysis
Chapter 4: Global Plasma Fractionation Major Regional Market Size and Forecast Analysis
Chapter 5: Global Plasma Fractionation Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Plasma Fractionation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Plasma Fractionation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Plasma Fractionation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Plasma Fractionation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Plasma Fractionation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Plasma Fractionation Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Plasma Fractionation Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Plasma Fractionation Market Overview 1.1 Product Definition and Statistical Scope 1.2 Plasma Fractionation Product by Type 1.2.1 Global Plasma Fractionation Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Albumin 1.2.3 Immune Globulin 1.2.4 Coagulation Factor 1.2.5 Others 1.3 Plasma Fractionation Product by Application 1.3.1 Global Plasma Fractionation Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Immunology 1.3.3 Hematology 1.3.4 Others 1.4 Global Plasma Fractionation Market Revenue Analysis (2019-2030) 1.5 Plasma Fractionation Market Development Status and Trends 1.5.1 Plasma Fractionation Industry Development Status Analysis 1.5.2 Plasma Fractionation Industry Development Trends Analysis 2 Plasma Fractionation Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Plasma Fractionation Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Plasma Fractionation Market Analysis by Regions 4.1 Plasma Fractionation Overall Market: 2023 VS 2024 VS 2030 4.2 Global Plasma Fractionation Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Plasma Fractionation Revenue and Market Share by Region (2019-2024) 4.2.2 Global Plasma Fractionation Revenue Forecast by Region (2025-2030) 5 Global Plasma Fractionation Market Size by Type and Application 5.1 Global Plasma Fractionation Market Size by Type 5.2 Global Plasma Fractionation Market Size by Application 6 North America 6.1 North America Plasma Fractionation Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Plasma Fractionation Market Size by Type 6.4 North America Plasma Fractionation Market Size by Application 6.5 North America Plasma Fractionation Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Plasma Fractionation Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Plasma Fractionation Market Size by Type 7.4 Europe Plasma Fractionation Market Size by Application 7.5 Europe Plasma Fractionation Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Plasma Fractionation Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Plasma Fractionation Market Size by Type 8.4 China Plasma Fractionation Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Plasma Fractionation Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Plasma Fractionation Market Size by Type 9.4 APAC (excl. China) Plasma Fractionation Market Size by Application 9.5 APAC (excl. China) Plasma Fractionation Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Plasma Fractionation Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Plasma Fractionation Market Size by Type 10.4 Latin America Plasma Fractionation Market Size by Application 10.5 Latin America Plasma Fractionation Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Plasma Fractionation Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Plasma Fractionation Market Size by Type 11.4 Middle East & Africa Plasma Fractionation Market Size by Application 11.5 Middle East & Africa Plasma Fractionation Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Plasma Fractionation Market Revenue by Key Manufacturers (2020-2024) 12.2 Plasma Fractionation Competitive Landscape Analysis and Market Dynamic 12.2.1 Plasma Fractionation Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Takeda 13.1.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Takeda Plasma Fractionation Product Portfolio 13.1.3 Takeda Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 CSL 13.2.1 CSL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 CSL Plasma Fractionation Product Portfolio 13.2.3 CSL Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Grifols 13.3.1 Grifols Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Grifols Plasma Fractionation Product Portfolio 13.3.3 Grifols Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Octapharma 13.4.1 Octapharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Octapharma Plasma Fractionation Product Portfolio 13.4.3 Octapharma Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Kedrion 13.5.1 Kedrion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Kedrion Plasma Fractionation Product Portfolio 13.5.3 Kedrion Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 LFB Group 13.6.1 LFB Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 LFB Group Plasma Fractionation Product Portfolio 13.6.3 LFB Group Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Biotest 13.7.1 Biotest Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Biotest Plasma Fractionation Product Portfolio 13.7.3 Biotest Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 BPL 13.8.1 BPL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 BPL Plasma Fractionation Product Portfolio 13.8.3 BPL Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 RAAS 13.9.1 RAAS Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 RAAS Plasma Fractionation Product Portfolio 13.9.3 RAAS Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.10 CBPO 13.10.1 CBPO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 CBPO Plasma Fractionation Product Portfolio 13.10.3 CBPO Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.11 Hualan Biological Vaccine 13.11.1 Hualan Biological Vaccine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 Hualan Biological Vaccine Plasma Fractionation Product Portfolio 13.11.3 Hualan Biological Vaccine Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.12 Tiantan Biological 13.12.1 Tiantan Biological Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.12.2 Tiantan Biological Plasma Fractionation Product Portfolio 13.12.3 Tiantan Biological Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.13 Shuanglin Bio-Pharmacy 13.13.1 Shuanglin Bio-Pharmacy Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.13.2 Shuanglin Bio-Pharmacy Plasma Fractionation Product Portfolio 13.13.3 Shuanglin Bio-Pharmacy Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.14 Boya Bio-Pharmaceutical 13.14.1 Boya Bio-Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.14.2 Boya Bio-Pharmaceutical Plasma Fractionation Product Portfolio 13.14.3 Boya Bio-Pharmaceutical Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.15 Yuanda Shuyang Pharmaceutical 13.15.1 Yuanda Shuyang Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.15.2 Yuanda Shuyang Pharmaceutical Plasma Fractionation Product Portfolio 13.15.3 Yuanda Shuyang Pharmaceutical Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.16 Weiguang? Biological 13.16.1 Weiguang? Biological Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.16.2 Weiguang? Biological Plasma Fractionation Product Portfolio 13.16.3 Weiguang? Biological Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.17 KM Biologics 13.17.1 KM Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.17.2 KM Biologics Plasma Fractionation Product Portfolio 13.17.3 KM Biologics Plasma Fractionation Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Plasma Fractionation Industry Chain Analysis 14.2 Plasma Fractionation Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Plasma Fractionation Typical Downstream Customers 14.4 Plasma Fractionation Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support